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Summary 
Commitment ofT helper 1 (Thl) or Th2 populations developing during an immune response 
to a pathogen, or an inappropriate immune response to an allergen or autoantigen, may deter- 
mine the difference between health and chronic disease. We show that strongly polarized Thl 
and Th2 populations assessed by immunoassay are heterogeneous using flow cytometry to de- 
tect single cells producing interferon */(IFN-~/) and interleukin 4 (IL-4). Thl populations aris- 
ing after 1 wk  of stimulation in  IL-12 plus anti-IL-4 antibodies  could convert to Th2 cells 
when restimulated in IL-4. Th2 populations resulting from stimulation for 1 wk in IL-4 could 
give rise to Thl cells upon restimulation in IL-12 plus anti-IL-4. In contrast, the cytokine pro- 
files  of long-term Thl  and  Th2  populations arising originally from repeated stimulation in 
IL-12 or IL-4 appeared more homogeneous and were not reversible, although IL-4 dramati- 
cally reduced the number of IFN-'?--producing Thl  cells.  This may explain previous reports 
that Thl cells can be converted to Th2 cells. 
D 
evelopment of the appropriate CD4 + Th subset dur- 
ing an immune response is critical for eradication of 
infectious organisms  (1-3).  These subsets  of Th cells may 
be distinguished by the pattern of cytokines that they pro- 
duce. Thl cells produce IFN-~/and lymphotoxin and play 
a critical role in directing cell-mediated immune responses, 
important for the clearance of intracellular pathogens. Th2 
cells producing IL-4, -5, -10, and -13, have been associated 
with allergy and are important for humoral responses (1--6). 
An important role for Th2-type cytokines, such as IL-4 and 
IL-10,  is  their  abihty  to  regulate  Thl  responses  (7-11) 
which are important for the clearance of infectious organ- 
isms but may also result in pathology if ehcited against self- 
antigens (12-14). 
Cytokines present during the initiation ofa CD4 + T cell 
response can determine the development of a particular Th 
cell phenotype (10,  15-19). Th2 cells develop when naive 
T  cells are stimulated in vitro in the presence of IL-4 (10, 
15,  17).  In addition, the presence of IL-4 during priming 
has also been shown to play an important role in vivo, for 
example,  in  establishing  a  Th2  nonhealing  response  in 
BALB/c mice to the intracellular parasite Leishmania major 
(20,  21).  Conversely, IL-12 is a critical factor driving the 
development  of  Thl  cells  from  antigen-specific  naive 
CD4 + T  cells (16,  18,  19); in addition, it enhances IFN-~/ 
production by Thl clones (22) and human Th2/Th0-type 
clones and activated Th cells  (23,  24). Despite the induc- 
tion of IFN-~/production by seemingly committed human 
Th2/Th0  clones  (23),  such  polarizing stimuli  as  IL-4 or 
IL-12 have been found to be most effective when delivered 
at the initiation of the immune response, both in vitro (10, 
15-19) and in vivo (20, 21, 25-27). 
P,  ecendy, ongoing Th2 responses to L. major were found 
to be reverted to a heating Thl  response when BALB/c 
mice were treated during chronic infection with Pentostam 
(to reduce the parasite infection) together with IL-12 (28), 
or by transferring the Th2 populations to scid mice under 
appropriate conditions (29, 30). In addition, polarized Thl 
populations  obtained  from  mice  infected  with  L.  major 
have been modified to produce Th2-type cytokines by re- 
culture in vitro with specific antigen, APCs, IL-2, and IL-4 
(31).  These data are reminiscent of studies in human sys- 
tems  that  demonstrated  that  purified protein  derivative- 
specific T  cells which normally outgrow with a Thl-like 
profile, can be selected as Th2-1ike if IL-4 is added early in 
bulk cultures  (32).  In  contrast to  the  in vivo studies  dis- 
cussed above showing the reversal of a Th2 phenotype, re- 
cendy it has been shown that although the phenotype of 
early Thl cells was efficiently reversed in vitro by addition 
of IL-4, Th2 cells were resistant to phenotype reversal (33, 
34).  Although in some cases,  these studies involve T  cell 
populations that are clonal with respect to their antigen re- 
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ulations  of Th  cells with  respect  to  cytokine production 
(35), and the level of commitment for cytokine production 
at the single cell level is unclear. To address this, and to ob- 
tain information on whether a switch in Th phenotype re- 
flects a true conversion or the suppression of the polarized 
phenotype by outgrowth and/or differentiation of uncom- 
mitted  precursors,  we  have  employed flow  cytometry to 
detect single cells producing IFN-~ and  IL-4  (35).  Using 
this technology we assessed the plasticity of seemingly po- 
larized Thl  and Th2 populations in an in vitro system us- 
ing CD4 + T  cells from TCR-transgenic mice (10, 36), re- 
stimulated  with  antigen  under  conditions  designed  to 
reverse their pattern of cytokine production. 
Materials and Methods 
Animals.  Mice transgenic for the D011.10  TCR-~/[3  on  a 
BALB/c genetic background (36) were identified at age 4-6 wk by 
staining peripheral blood leukocytes with the anti-TCR clonotype- 
specific mAb KJ1-26 (37, 38). All transgenic mice used were het- 
erozygous for the  TCR  0t  and  [3 transgenes.  Female nontrans- 
genic BALB/c mice between 6  and 10 wk old were purchased 
from Simonsen Labs (Gilroy, CA). 
Th Cell Clones.  Stimulation and maintenance of  long-term Th 
clones was as previously described: Thl, HDKI (BALB/c-derived, 
KLH specific, I-A  a restricted; 39)  and Th2,  CDC25  (C3D2/F1/ 
J-derived, normal rabbit IgG specific, H-2I  d restricted; 40). Short- 
term Th clones derived from unimmunized DOl1.10 TCR-a/[3 
transgenic mice were obtained by sorting single cells on the basis 
of CD4 +, leukocyte endothelial cell adhesion molecule (LECAM) ~ 
lbn~  t, KJ1-26 + into 96-well microtiter wells containing 105 irra- 
diated splenic APCs (3,000  rad) plus OVA (0.3  IxM) under the 
following conditions: Thl clones, in the presence oflL-2 (10  v U/ 
mg, 330 U/n'd), IL-12 (106 U/mg, 100 U/ml; plus small amounts 
of 1L-4,  which  were  required  to  maintain  cell viability), plus 
TGF-[3 (2 ng/ml); Th2 clones, in the presence oflL-2 (330 U/ml) 
and  large  amounts  of IL-4  (107 U/mg,  100  U/ml);  and  Th0 
clones, in the presence of IL-2 (330 U/n-d), IL-4 (15 U/ml), and 
IL-12  (10  U/ml).  All the DO11.10-derived clones were  100% 
positive for the clonotype antibody, KJ1-26 (cells are referred to 
as clones when they have been derived from a single cell in cul- 
ture, as opposed to populations described below, which although 
carrying the same transgene and thus antigen specificity, were not 
derived from single cells  in  culture).  Clones were  restimulated 
and expanded under the  respective conditions every 2  wk.  All 
clones were expanded and maintained in RPMI 1640 (JR Scien- 
tific Inc.,  Woodland, CA)  containing  10%  FCS  (JR  Scientific 
Inc.), t-glutamine (2 raM), penicillin (100  U/n-d), streptomycin 
(100  Ixg/m/), Hepes buffer (10  raM), sodium pyruvate (1 mM), 
2-mercaptoethanol (0.05  raM,  Sigma Chemical Co.,  St.  Louis, 
MO),  (complete RPMI),  supplemented with mouse rlL-2 (330 
U/tul),  and  the  respective initiating conditions were  used  for 
growth of the clones. In some cases, clones were stored in liquid 
nitrogen and cells were thawed into medium containing murine 
rlL-2 (330 U/m/), as above, 5-7 d before assay. 
Rested T  cell clones were washed, counted, and resuspended 
1Abbreviation used in this paper: LECAM, leukocyte endothelial cell adhe- 
sion molecule. 
at 2  ￿  10S/well. They were restimulated with irradiated (3,000 
rad) splenic APCs plus specific antigen or PMA (50 ng/ml) plus 
ionomycin (500  ng/ml)  for 4  h  at 37~  with Brefeldin A  (10 
bLg/ml; Epicentre Technologies, Madison, WI) added for the last 
2 h, for flow cytometric analysis ofintracellular cytokine staining. 
Identical stimulations of T  cells were set up in parallel but in the 
absence of Brefeldin A, for 48 h at 37~  for analysis of IL-4 and 
IFN-"/ in supernatants by immunoassay as previously described 
(41-43). 
Culture Medium,  Cytokines,  Antibodies and Antigens,  and other Re- 
agents.  Cell cultures were  maintained in  cRPMI  as  described 
above, but usually without supplemented cytokines, unless indi- 
cated. 
Recombinant mouse  cytokines were  obtained from  the  fol- 
lowing sources: IFN-'y (Schering Research, Bloomfield, NJ), IL-4 
(Dr. S. Menon, DNAX Research Institute), TGF-[3 (R&D Sys- 
tems, Inc., Minneapolis, MN), and IL-2 (a kind gift from Gerard 
Zurawski, DNAX Research Institute). Recombinant mouse IL-12 
was obtained by transfecting COS7 cells with the cDNA encod- 
ing the p35 and p40 cDNA as described previously (44),  which 
was  obtained by PCR  cloning using published sequences  (44). 
Supernatants from mock-transfected cells were used as a control 
and showed no effect in the concentration range at which IL-12 
was  used.  The  IL-12  content  of the  supernatants  ranged from 
2,000 to 10,000 U/ml (22). 
Purified rat anti-mouse IL-4 (11B11)  and anti-IFN-',/ (AN18) 
antibodies previously described (42, 45), and an isotype-matched 
control were supplied by J. Abrams (42; DNAX Research Insti- 
tute), mAbs used for flow cytometric sorting or analysis included 
anti-mouse  CD4-PE  and  LECAM-1-FITC  (both  from  Phar- 
Mingen, San Diego, CA). Additional anticytokine mAbs for im- 
munoassay and flow  cytometry, induding anti-mouse IL-4 and 
IFN-y reagents, were purified from serum-free hybridoma super- 
natants as previously decribed (42). 
The  antigenic OVA-peptide (0VA323_339)  from chicken OVA 
was  synthesized on  a  peptide synthesizer (model 430;  Applied 
Biosystems, Lewisville, TX).  100  Ixg/ml KLH and  500  txg/ml 
rabbit IgG (Sigma Chemical Co.) were used. 
Preparation of T  Cells and APCs.  CD4 + T  cells were enriched 
by  negative  selection  using  Magnetic  Activated  Cell  Sorting 
(MACS) with a cocktail ofbiotinylated anti-mouse CD8e~, I-A  d, 
B220,  and Mac-1  antibodies as previously described (35)  (Mil- 
tenyi,  Sunnyvale,  CA).  T  cells staining positive for  CD4  and 
LECAM-1  were  further  purified by  positive selection using  a 
FACStar  Plu~|  flow cytometer (Becton Dickinson & Co., San Jose, 
CA) to achieve 99.8% CD4 + T  cells.  Staining did not alter the 
function of the T  cells (not shown). 
Stimulation  of Transgenic CD4  + T  Cells for Cytokine  Production. 
Primary stimulations of CD4 + T cells (2.5  ￿  10S/well)  were car- 
fled out using OVA peptide (0.3  IxM) and nucleated spleen cells 
(5  ￿  106/well, 3,000 rad) as APCs in a total volume of 2 ml in 
24-well plates. In addition, some cultures received cytokines ([IL-4 
(200 U/ml)] or IL-12 [10 U/ml]) or mAbs to block endogenous 
cytokines  (anti-IL 4  [10  I.tg/ml]). T  cells  were  expanded  and 
maintained in the same culture conditions for 1 wk.  Cells were 
then harvested on day 6, washed three times, counted, and a por- 
tion of them resnspended at 2 ￿  105/well, and restimulated with 
PMA (50  ng/ml) plus ionomycin (500  ng/ml) for 4 h  at 37~ 
with Brefeldin A  (10  I~g/ml) added for the last 2 h  (to enhance 
flow cytometric analysis ofintracellular cytokine staining). The cells 
were then ftxed and and stained for detection of intracellular cy- 
tokine synthesis as described below. Identical stimulations ofT cells 
were set up in parallel but in the absence of Brefeldin A, for 48 h 
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noassay as described below. 
Additionally, naive CD4  + T  cells were stimulated  in primary 
cultures,  under the same conditions as above, but in this case the 
stimulations  were repeated weekly for three  consecutive weeks 
(chronic stimulation) before washing, harvesting, restimulating,  and 
analyzing as above. 
For phenotype reversal studies,  cultures  of Th cells developed 
from naive CD4  + T cells were stimulated  under the above condi- 
tions either once or repeatedly for three consecutive weeks. Cells 
were washed and then recultured under the same conditions with 
APCs and antigen alone, or in the presence of the same polarizing 
stimulus,  or an oppositely polarizing stimulus  (IL-4 or IL-12 plus 
neutralizing  anti-IL-4 antibodies),  for I wk or repeatedly for three 
consecutive weeks. The cells propagated under all the different con- 
ditions and time points were  100% CD4  +, KJ1.26 +. Cells were 
then washed, harvested, and restimulated before analyzing as above. 
Cytokine Assays.  IFN-7 was detected using a two-site sand- 
wich ELISA (41, 42, 46) which has a lower limit of sensitivity of 
125 pg/ml (1 U/ml or 100 pg/ml). The ELISA for IL-4 has been 
described previously (41, 42) with a lower limit of sensitivity  of 
100 pg/ml. 
Flow Cytometric Analysis of Intracellular IFN-T and IL-4 Synthesis. 
Cells were resuspended at 105-106/ml and stimulated  with PMA 
at 50 ng/ml plus ionomycin at 500 ng/ml. 2 h before cell harvest, 
Brefeldin A was added at 10 p,g/ml, using a stock of I mg/ml in 
ethanol  (100%). Cells were harvested,  washed,  and resuspended 
in PBS with Brefeldin A before adding an equal volume of 4% 
formaldehyde fixative (final concentration 2%). After fixing for 20 
min at room temperature, cells were either stored at 4~  for up to 
2 d, or stained immediately for cytokines using a modified method 
(35) based on that described by Assenmacher et al. (47) and others 
(48,  49).  For intracellular  staining,  all reagents  and washes  con- 
tained 1% BSA and 0.5% saponin (Sigma Chemical Co.), and all 
incubations were  at  room temperature.  Cells  were washed and 
preincubated  for  10  rain  in  PBS/BSA/saponin,  and  incubated 
with anti-IL-4 (11Bll)  at  5  b~g/ml or isotype-matched control 
GLl13 (isotype control)  at 10 p,g/ml for 30 rain. After two washes 
and blocking with rabbit serum/0.5% saponin,  optimal concentra- 
tions of FITC anti-rat Ig (antibody raised in rabbit;  Vector Labo- 
ratories,  Inc., Burlingame, CA) were added for 30 min. After two 
washes,  purified rat  Ig was  added at 300  btg/rnl  for 10 rain to 
block residual anti-rat Ig binding. Without washing,  anti-IFN-~/ 
(AN18-PE) (or control PE-conjugated rat Ig, Pharmacia,  Piscat- 
away, NJ) was added at a 2.5-p,g/ml final concentration. After 20 
min,  cells were washed twice with PBS/BSA/saponin and then 
with  PBS/BSA  without  saponin  to  allow  membrane  closure. 
Cells were then stained with the clonotypic antibody KJ1.26  (36) 
to confirm the presence of 100% OVA-specific TCR-transgenic 
CD4 + T  cells. Data are  displayed  as bivariate  dot plots. Samples 
were analysed on a FACScan  |  flow cytometer (Becton Dickinson 
& Co.). Thresholds were set on control stains (included for every 
sample  at  every time  point)  to lie  on the  first  percentile  (not 
shown) as previously described (35). Our previous study confirms 
the specificity  of detection of intracellular  cytokine synthesis by 
this  method  (35).  Results  were  analyzed  using  Lysis II  and 
Cellquest software. 
Results and Discussion 
Reversal of the  Cytokine  Profile of Th I  or Th2 Populations 
Generated by Stimulation for 1 wk in the Presence of Polarizing 
Stimuli.  We have previously demonstrated that naive CD4 + 
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T  cells from the DOl1.10 OVA-specific TCR-~x/[3 trans- 
genic mouse can be induced to develop into either Thl  or 
Th2  populations,  when stimulated  for  1 wk with  specific 
antigen and APCs in the presence of IL-12 or IL-4, respec- 
tively (10,  16, 35, 36). Although, these Th populations ap- 
peared  to be  completely polarized  as  assessed by levels  of 
IFN-~/or IL-4 detected in the supematants by immunoas- 
say after T  cell activation (10,  16, and Figs.  1 A  and 2  C), 
the composition of the population with respect to cytokine 
production by single cells, or their level of commitment to a 
particular cytokine profile, was unclear. Using flow cytom- 
etry to detect single cells producing IFN-~/and IL-4 (35), 
we assessed the possible heterogeneity and plasticity of these 
polarized Thl and Th2 populations when restimulated with 
antigen under conditions  designed to reverse their pattern 
of cytokine production (Figs.  1 and 2).  To produce polar- 
ized Th  cell populations,  naive  CD4 +,  LECAM-1  b~ght, T 
cells from DOll. 10 TCR-et/[3-transgenic mice were stim- 
ulated with OVA and irradiated splenic APCs for 1 wk, in 
the presence of either IL-4 to produce Th2 populations, or 
IL-12 (plus or minus anti-IL-4 mAb) to produce Thl  pop- 
ulations (10,  16). 
Naive CD4 + T  cells stimulated with antigen and APCs in 
the presence of IL-4 for 1 wk gave rise to Th2 cells since 
supematants obtained 48 h  after stimulation contained IL-4 
but not IFN-~/, as detectable by immunoassay (Figs.  1 A and 
2  C).  Flow  cytometric  analysis  of these  Th2  populations 
showed that they consisted predominantly of IL-4--produc- 
ing cells  (>50%)  (Figs.  1  B  and 2  A).  A  small percentage 
(4%)  of the cells still  synthesized IFN-~/, showing that the 
population  was  actually heterogeneous,  although  this  cy- 
tokine was not detectable in the supernatants (Figs.  1 A  and 
2  C).  Although the flow cytometric analysis of these Th2 
populations suggested that "-~40% of the cells did not pro- 
duce IL-4, this may be explained by our previous observa- 
tions, where we have shown that IL-4 synthesis is relatively 
transient  in Th2  clones  (35).  This  transient  production  of 
IL-4 protein  correlates  with  transient  expression  of IL-4 
mRNA  (50).  Since the  cells are not synchronously in cell 
cycle  (35),  or possibly  not  synchronously secreting  IL-4, 
and since IL-4 production is short-rived, it is unlikely that 
it  will be possible  to observe  100%  of cells  within  a  Th2 
population producing this cytokine simultaneously (35).  It 
is also possible that some of these cells staining negative for 
IFN-~/ or IL-4 synthesis represent undifferentiated precur- 
sors, which do not produce these cytokines, or produce low 
levels of IFN-~/and IL-4, which are below the level of de- 
tectahility.  Th2  populations  also  developed  (11%  produc- 
ing IL-4 only),  although to a lesser extent,  upon stimula- 
tion with  antigen  and APCs alone,  reflecting endogenous 
IL-4 in the cultures (35; Figs.  1 B and 2 A). 
We tested the ability of Th2 populations to be converted 
to a Thl  phenotype after  1 wk of stimulation in the pres- 
ence of IL-4 (Figs.  1 and 2), by restimulation with antigen 
for 1 wk  (Fig.  1  C)  or weekly for 3  wk  (Fig.  2  B)  under 
conditions  designed to reverse  the phenotype.  Restimula- 
tion of Th2 cells for 1 wk in the presence oflL-12 and anti- 
IL-4 mAbs initiated a change in phenotype as seen by im- Figure 1.  Keversal of cytokine profiles in 
early Thl  and Th2 populations. LECAM- 
1  b~igh~,  CD4  +  T  cells from  TCR-ot/13 
DOl1.10 transgenic mice were first stimu- 
lated for 1 wk with splenic APCs and OVA, 
in either medium alone, with IL-4, or IL-12 
plus or minus anti-IL-4, as described in Ma- 
terials and Methods. Cells were harvested 
and a portion of them restimulated for anal- 
ysis of supernatants for IFN-3  t and IL-4 by 
immunoassay (A), or of cells by flow cy- 
tometry (B and C), as described, to deter- 
mine their Th  phenotype.  Frequencies of 
IFN-'y--producing cells are  shown on  the 
y-axis and IL-4--producing  cells on the x-axis. 
After  1  wk  of antigenic  stimulation  (as 
above) the remaining CD4 + T ceils (100% 
KJ1-26  +) propagated from each group were 
washed and resdmulated under conditions 
designed to achieve phenotype reversal (and 
controls), for 1 wk as described in Materials 
and Methods, and supematants were ana- 
lyzed by immunoassay  or ceils were analyzed 
by flow cytometry for IFN-~/and IL-4 pro- 
duction, as above, after appropriate restimu- 
lafion. 
munoassay (Fig. 1 A). Analysis at the single cell level showed 
the emergence of  a distinct population of  Thl  cells produc- 
ing IFN-~/only (12%)  (Fig.  1  C).  The frequency of IL-4-- 
producing cells in Th2 populations restimulated with IL-12 
and anti-IL-4 was only slightly diminished (51-39%), whereas 
restimulation  in the presence of exogenous IL-4 enhanced 
their frequency (51-79%; Fig.  1 C). Distinct populations of 
IFN-~/-producing  cells  also  appeared  when  Th2  popula- 
tions were restimulated repeatedly (for 3 wk) in IL-12 plus 
anti-IL-4 (Fig. 2  B). In this case, an enhanced frequency of 
Thl  cells  producing  IFN-~/  (>25%),  as  well  as  Th0  cells 
(51-53)  producing both  IL-4 and IFN-% were seen  (7%) 
(Fig. 2 B). This apparent change from a Th2 to a Thl  phe- 
notype  was  also  observed  upon  immunoassay  of super- 
natants  from these  Th cell populations  upon restimulation 
(Fig.  2  C).  These Th2 cells,  although very similar in their 
cytokine profile  as  measured  by immunoassay,  are poten- 
tially different from those of Szabo et al.  (34),  since in the 
present study, endogenous IL-12 was not neutralized  dur- 
ing primary stimulation. 
We  also examined  the stability  of Thl  populations  de- 
rived from stimulation for 1 wk with antigen and APCs in 
the  presence  of IL-12  plus  anti-IL-4  mAbs,  which  pro- 
duced high levels oflFN-~/and undetectable IL-4 upon re- 
stimulation  (Figs.  1  A  and  2  C).  In  agreement  with  this, 
flow cytometric analysis of the cells within  this population 
showed that they produced excusively IFN-~/(>80%)  and 
no IL-4 (Figs.  1 B and 2 A), upon restimulation with PMA 
and ionomycin. Approximately 20% of cells stained  nega- 
tive  for IFN-~/ and  IL-4 production,  suggesting that  they 
may be  undifferentiated  precursors  producing  neither  cy- 
tokine.  Alternatively,  these  cells  could be  producing low 
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Restimulation  of these  strongly polarized  Thl  cells  with 
antigen  for  1  wk in  the  presence  of IL-4 diminished  the 
IFN-7 levels and enhanced IL-4 levels in the supernatants 
(Fig.  1 A).  Single  cell analysis  revealed a  small number of 
Th2 cells  excusively producing IL-4 (8%,  Fig.  1 C). How- 
ever, repeated stimulation of the Thl  cells for 3 wk in the 
presence of IL-4 (Fig.  2  B) generated larger frequencies of 
cells  producing IL-4 (38-41%).  This was accompanied by 
increased levels of IL-4 in the supernatants (Fig.  2  C), sug- 
gesting that outgrowth was required to achieve the switch. 
The changes in the cytokine profiles of both Thl and Th2 
populations  were  only seen if the  conditions  required  to 
achieve phenotype reversal were  applied during antigenic 
stimulation,  and  this  was  often  accompanied by dramatic 
cell death in the cultures (data not shown). 
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Figure 2.  Reversal  of phenotype in early 
Thl and Th2 populations is more marked 
after repeated stimulation in oppositely  po- 
larizing stimuli. Cells were treated and ana- 
lyzed as in Fig. 1, except that after the initial 
1 wk of stimulation, the cultures were re- 
peatedly stimulated for 3 wk in oppositely 
polarizing stimuli, to reverse the Th pheno- 
type (and controls) as above. The various 
populations were analyzed as described in 
Fig.  1 after stimulation in PMA and iono- 
mycin, for IFN-7 and IL-4 production by 
immunoassay  or flow cytometry. 
The most dramatic observation, however, was the ability 
of added  IL-4  to  significantly  diminish  the  frequency  of 
Thl cells producing IFN-~/(81-10%, Figs.  1 and 2) after as 
little as 1 wk of restimulation (Fig.  1 C). This was also re- 
flected by the decreased levels of IFN-~ detectable in the 
supernatants  of the  same cells  by ELISA (Figs.  1 A  and 2 
C). In contrast,  the frequencies of IL-4-producing cells in 
polarized populations of Th2 cells remained relatively stable 
even when repeatedly stimulated in the presence of IL-12 
plus anti-IL-4 mAbs (51-40%, Fig. 2 B). 
Thus, although IL-4 and IFN-~/cytokine profiles in the 
supematants of stimulated early Thl  and Th2 populations 
indicated commitment of naive cells towards a strongly po- 
larized Th2  or Thl  phenotype, further stimulation in  op= 
positely polarizing conditions  converted the cytokine pro- 
file  of these  populations  (Figs.  1  A  and  2  C).  However, such analysis of cytokines in the supernatants gives no in- 
formation on the identity of the cells within the popula- 
tion, or the level of heterogeneity or commitment for cy- 
tokine  production  at  the  single  cell  level.  Furthermore, 
immunoassays are limiting since they cannot determine the 
presence of cells producing both IFN-~/and IL-4 simulta- 
neously, or cells producing neither of these cytokines. It is 
possible  that not all  the  IFN-~/-  or IL-4-producing cells 
within the early Thl or Th2 populations are fully commit- 
ted after a primary stimulation with antigen, but rather re- 
tain their ability to respond to signals in their environment 
(see Fig.  6 A). The flow cytometric analysis  of single cells 
producing IFN-~/and IL-4 shows that early Thl and Th2 
populations are heterogeneous. Taken together, our studies 
suggest that an apparent reversal of phenotype may reflect 
clonal outgrowth of a  combination of a small  number of 
contaminating Th cells of the opposite phenotype, and dif- 
ferentiating uncommitted precursors, rather than dediffer- 
entiation of Thl or Th2 cells. 
Th I  and Th2 Populations Generated by Chronic Stimulation 
with Antigen  in the Presence of Polarizing Stimuli Are Irrevers- 
ible.  Thl  and  Th2  clones  have  been  generally selected 
from polarized T  cell populations derived from hyperim- 
munized  mice,  or  from mice  or  humans  suffering from 
chronic infectious disease or allergy (1-4). It has been diffi- 
cult to reverse the phenotype of such chronic Thl or Th2 
responses in vivo (20,  21, 25-27, 54--56).  To simulate po- 
larized Th cell populations isolated in chronic disease,  we 
repeatedly stimulated naive CD4 + T  cells under polarizing 
conditions and then assessed the heterogeneity and plastic- 
ity of cytokine-producing cells at the single cell level. 
CD4 + T  cells from TCR-ot/f3 DOl1.10 transgenic ani- 
mals,  stimulated with splenic APCs and OVA for 3 wk in 
medium alone or in the presence of IL-4, showed a shghtly 
more dominant Th2 phenotype (>66% cells producing IL-4 
only; Fig.  3 A) than Th2 populations arising after 1 wk of 
stimulation in IL-4 (Figs.  1 B and 2 A). This was reflected 
by higher levels of IL-4 in the supernatants of these polar- 
ized  populations  upon  restimulation  (Fig.  3  C).  These 
chronically  derived  Th2  populations  remained  relatively 
stable,  even upon repeated restimulation under conditions 
designed to  reverse their cytokine profile, with  only the 
emergence of  small subpopulations (<4%) expressing either 
IFN-% or IFN-',/and IL-4 (Fig. 3 B). 
Highly polarized Thl cells developed from repeated stim- 
ulation of naive CD4 + T  cells for 3 wk with antigen and 
APCs,  in the presence of IL-12 and anti-IL-4  (92% pro- 
duced IFN-31 only; Fig. 3 A). These Thl populations could 
not be redirected towards a Th2 phenotype by repeated re- 
stimulation in the presence of IL-4 (Fig. 3 B), in contrast to 
the polarized Thl populations arising after 1 wk of  stimulation 
under the same conditions (Figs.  1 C and 2 B). Again, the 
single cell analysis of IFN-~- and IL-4-.producing cells was 
in  keeping with,  although  again  more  informative  than, 
standard immunoassay of these cytokines in the supematants 
of  stimulated Thl cells (Fig. 3 C). Such resistance to a reversal 
in  their cytokine profile is  likely to  be  due  to  increased 
commitment  and  homogeneity among  IL-4-- or  IFN-'y- 
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producing cells with time, as well as decreased numbers of 
precursors, since there is no further source of naive or un- 
committed cells in the cultures (see model in Fig. 6 B). 
Thl  and Th2 populations arising after chronic stimula- 
tion of CD4 + T  cells in the presence of polarizing condi- 
tions greatly resembled those populations arising after short- 
term stimulation, with a few subtle differences (Figs.  1-3). 
First,  the number of IL-4-producing cells within the Th2 
population was slightly increased after repeated stimulation 
in IL-4 (from 51% after 1 wk, to 66% after 3 wk). This was 
also the case for the IFN-'y-producing cell number within 
the Thl population (from 81% after 1 wk, to 92% after 3 
wk). In both situations this was accompanied by a slight de- 
crease in  the  number of double negative  cells  producing 
neither IFN-'y nor IL-4, which could have resulted from 
their differentiation to IFN-~/- or IL-4-producing cells, or 
from a lack of survival in the cultures. In addition, in short- 
term cultures, small percentages of contaminating Th cells 
of the  opposite phenotype were sometimes detectable by 
flow cytometry (Figs. 1 and 2), although not always by im- 
munoassay (Figs. 1 A and 2 C), and these contaminants of- 
ten  decreased  with  repeated  stimulation  in  a  polarizing 
stimulus (Fig. 3 A). These subtle differences in the Th 1 and 
Th2 populations arising after 1 wk of stimulation, as com- 
pared to those arising from repeated antigenic stimulation 
in  the  polarizing stimuh,  may account for differences in 
their level of  commitment for production oflFN-',/or IL-4. 
It  is  interesting  to  note  that  repeated  stimulation  of 
CD4 + T cells with IL-12, in the absence ofanti-IL-4 mAbs 
(Fig. 3 A) resulted in the development of large percentages 
of Th0  cells  that  produced  both  IFN-~/  and  IL-4.  This 
population undoubtedly resulted from repeated stimulation 
in  the  presence  of endogenous  IL-4  and  IL-12,  and  ap- 
peared to be relatively unstable,  disappearing when  there 
was  an alteration in the ratio of IL-4 to IL-12 in the cul- 
tures. Whether polarized populations of Thl and Th2 cells 
differentiate via an intermediate population producing both 
IFN-~ and IL-4, as previously proposed, is still unclear (57). 
When naive CD4 + T  cells were stimulated repeatedly in 
IL-12 alone,  a dominant Thl  population emerged, how- 
ever, these populations also gave rise to 9% of cells produc- 
ing IL-4 alone, or 5% IFN-~/and IL-4 simultaneously (Fig. 
3 A). The increase in IL-4 single positives as well as the IL-4 
plus IFN-~ double positives (Fig. 3 A) in the 3- versus 1-wk 
stimulation  (Figs.  1 B and 2 A)  may be due to increasing 
amounts of endogenous levels of IL-4 produced upon re- 
peated stimulation. This is supported by the lack of IL-4- 
producing  cells  and  dominant  Thl  phenotype  which 
emerges  from cultures  repeatedly stimulated  in  the  pres- 
ence of IL-12 and anti-IL-4  (Fig.  3 A).  Thl  populations 
derived from 3-wk  stimulations in the presence of IL-12 
showed no dramatic decrease in IFN-~/-producing cells, al- 
though  the brightness  of the  stain was  diminished,  when 
repeatedly stimulated  in  the  presence of IL-4.  However, 
anti-IL-4 plus IL-12 markedly increased the frequencies of 
IFN-~/-producing cells (Fig.  3 B). In addition, cells simul- 
taneously producing IFN-~ and IL-4 appeared to be rela- 
tively unstable (Fig. 3, A and B). 
Thl and Th2 Population Reversibility Is Lost  after Long-term Stimulation Although  the  Thl  and  Th2  populations  arising  from 
chronically stimulated CD4 +  T  cells were  resistant to  re- 
version ofphenotype, cultures of polarized Thl populations 
restimulated in the presence of IL-4 showed a marked de- 
crease  in  IFN-~/-producing cells  (Fig.  3  B;  92-46%),  as 
with  the  data  obtained with  uncommitted Thl  popula- 
tions, presented in Figs.  1 and 2.  In contrast, the frequen- 
cies of IL-4-producing cells in polarized Th2 populations 
did not decrease significantly in the presence of IL-12 and 
anti-IL-4 (Fig. 3  B), nor increase significantly in the pres- 
ence of exogenous IL-4. 
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Figure  3.  Long-term  Thl 
and  Th2  populations are  irre- 
versible. Th effector populations 
were derived as described in Ma- 
terials and Methods (Fig. 1), ex- 
cept  that in this case, cultures 
from naive CD4  + T  cells were 
stimulated weekly for 3 wk with 
splenic APCs and OVA in the 
culture conditions described in 
Fig.  1.  A  portion  of the  cells 
were harvested after 3 wk,  re- 
stimulated with PMA and iono- 
mycin, and analyzed for IFN-'I 
and IL-4 production by immu- 
noassay and by flow cytometry  as 
above  (Fig.  1)  The  remaining 
CD4  +  T  cells (100% KJ126  +) 
were  washed and  restimulated 
weekly for 3 wk at 2.5  ￿  10s/ 
well  with  irradiated splenic 
APCs plus OVA in culture con- 
ditions designed to  reverse the 
phenotype (and controls) as de- 
scribed above (Fig. 1). Cells  were 
then restimulated  with PMA and 
ionomycin, and IFN-'y and IL-4 
production was assessed by im- 
munoassay and by flow cytome- 
try as above. 
In summary, Thl and Th2 populations arising after 1 wk 
of stimulation, although apparently strongly polarized, are 
still heterogeneous with respect to differentiation and com- 
mitment, possibly as a  result of cytokine receptor expres- 
sion or the  engagement of a  particular signaling pathway 
(34). It is likely that repeated stimulation results in a higher 
degree  of homogeneity and renders the  population more 
resistant to  change.  It is  interesting to  note that although 
highly committed Th populations do not appear to acquire 
the ability to produce cytokines of the opposite Th profile, 
Thl cells may be induced to lose their capacity to produce [FN-%  In contrast,  IL-4-producing cells appear more re- 
sistant to the effects of IL-12 and anti-IL-4 mAbs, perhaps 
reflecting rapid loss of IL-12 receptors for Thl  induction 
(34).  It is possible that this may be specific for the BALB/c 
genetic  background  on  which  this  TCK-ix/I3  transgenic 
mouse was made, since we have reported that mice on this 
background have a "defect" inasmuch as they default to the 
Th2  pathway  under  neutral  conditions  during  secondary 
stimulation.  However, our data may explain previous sug- 
gestions that it is possible to,reverse the phenotype of early 
Thl  T  cells  by addition of IL-4, but not of early Th2 cells 
by addition of IL-12 (31, 33, 34). Thus the reported appar- 
ent reversal of a Thl- to a Th2-type phenotype may result 
from the disappearance of IFN-~/-producing cells in com- 
bination  with  differentiation  and/or  clonal  outgrowth  of 
Th2 cells.  This reversal is more difficult to achieve in Th2 
cells,  since  IL-4--producing cells appear to be much more 
resistant to downmodulation (33, 34). 
Th l  and  Th2  Clones Have an Irreversible Phenotype: IL-4 
Reduces the Frequency of lFN-  y--produdng Cells by Th l  Clones 
Resulting in Marked Inhibition of lFN- y Secretion.  To  assess 
whether the IL-4-induced reduction in IFN-~/production 
by long-term Thl populations reflected a population of still 
uncommitted  cells,  a  panel  of antigen-specific  clones  de- 
rived from single cells were selected from hyperimmunized 
mice. These clones, which represent a completely differen- 
tiated  population,  were  tested  similarly  by stimulation  in 
the presence of oppositely polarizing stimuli (Figs. 4 and 5). 
As expected, resting Thl and Th2 clones repeatedly stimu- 
lated with antigen, in the presence of oppositely polarizing 
stimuli,  did not reverse their cytokine profile,  indicating a 
committed phenotype.  However, repeated antigenic stim- 
ulation of the Thl  clones in the presence of IL-4 again re- 
sulted in a significant reduction  of IFN-~/-producing cells 
or a diminishment in their brightness of staining (Fig. 4), as 
shown by FACS  |  analysis, and more dearly decreased lev- 
els  of IFN-~/ in supematants  as  detected  by immunoassay 
(Fig.  5).  Conversely, addition of IL-12 plus  (or minus, not 
shown) anti-IL-4 mAbs resulted in increased percentages of 
Thl  cells staining brightly for IFN-~/(Fig. 4), which corre- 
lated  with  increased  levels  of IFN-~/  in  the  supernatants 
(Fig.  5).  IL-4's effects were only seen by immunoassay in 
chronic stimulations,  since in the short term,  this cytokine 
either shows no effect or actually enhances IFN-~/secretion 
by acting as a growth or viability factor for Thl  clones (7, 
and Murphy, E., and A. O'Garra, unpublished observations). 
Again, little effect was observed on IL-4-producing cells in 
Th2  clones  after  repeated  stimulation  in  the  presence  of 
anti-IL-4  (not shown)  or IL-12 and anti-IL-4 mAbs (Fig. 
4). The mechanism oflL-4's ability to downregulate IFN-~  ~- 
producing cells in differentiated Thl  cells  is unclear at this 
stage.  It is  possible  that  IL-4 mediates  its  effects  on  Thl 
clones by downregulating endogenous levels of IL-12 pro- 
duced by splenic APCs.  However,  it is important  to note 
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Figure  4.  Cytokine  phenotype  of 
Thl  and  Th2  clones  is  irreversible: 
IL-4 downmodulates IFN-'?-producing 
cells. Long-term established Thl clones 
HDK1  (a)  and HDK-2  (c)  (KLH spe- 
cific, I-A  a restricted), and Th2  clones, 
CDC25  (e)  (rabbit Ig specific, C3D2/ 
F1); or short-term Thl  (b) and Th2 (d) 
clones (CD4  § OVA-specific  T cells de- 
rived  from  single  cell cultures  from 
DO10 TCR-ot/~ transgenic mice; 35) 
were tested for  their ability to  retain 
their respective phenotypes. Resting T 
cell clones (2  X  105/well) were first 
stimulated with  PMA and  ionomycin 
and analyzed for intraceUular IFN-~ and 
IL-4 as above (Fig. 1 A) to assess their 
basal state (.4). T cell clones were then 
tested for their ability to retain their re- 
spective  phenotype  when  stimulated 
weekly for 3 wk with  antigen (KLH, 
100  ~g/ml;  rabbit Ig,  500  I~g/ml; 
OVA-peptide, 0.3  ~M)  and irradiated 
splenic APCs (3,000 tad) in the presence 
of IL-2 (100 U/ml) alone, or in combi- 
nation with IL-4 (20 ng/ml), or IL-12 
(10 U/ml)  plus anti-IL-4 (10 p.g/ml). 
Resulting populations were restimulated 
with PMA and ionomycin and analyzed 
for  intracellular cytokine synthesis as 
above (B). 
908  Thl and Th2 Population Reversibility  Is Lost after Long-term Stimulation Figure 5.  IL-4 significantly  downregulates IFN-~/production  by Thl clones. Th clones were treated essentially as in Fig. 4, except that the final re- 
stimulation with PMA and ionomycin was for 48 h, after which supernatants were collected for immunoassay of IFN-'y and IL-4 production. 
that this  effect of IL-4 on IFN-~/production  added during 
repeated antigenic stimulation is still observed upon imme- 
diate  restimulation  of the  cells with  PMA  and ionomycin, 
in the absence oflL-4 and the splenic APCs. 
These findings may explain previous data demonstrating 
a reduction  in IFN=~/levels by IL-4 during a delayed-type 
hypersensitivity response to L. major  in vivo (11). Thus, in an 
in vivo setting, where undoubtedly  a heterogeneous  popu- 
lation  exists,  despite  the  dominant  function  of extremely 
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polarized  clones  obtained  from  individuals  during  certain 
infectious diseases (54, 58-64),  or autoimmune pathologies 
(12,  14,  65-68),  the  disappearance  of IFN-~/-producing 
cells could suggest an absolute change from a Thl  to a Th2 
phenotype. 
Implications for Immunotherapy  in  Chronic Diseases Arising 
from  Infection, Allergy,  or  T  Cell-mediated  Autoimmunity. 
These studies may provide new approaches for therapeutic 
intervention  during  chronic  disease.  It is likely  that  even + 
O 
Reversible 
IFN'~{++ ~  IL'4++ 
Uncommited Precursors (IL-2) 
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'rr=ble 
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IrN-~  ++++  Thl  ~  Th2  IL-4  ++++ 
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Th0 cells (IFN-~': IL-4  +) 
Naive CD4  + T cells (IL-2) 
Recently Emerging Thymocytes 
during chronic  disease, manifested by high levels of Thl- 
or  Th2-type  cytokines,  that  the  population  of CD4 +  T 
cells in a draining lymph node consists of a spectrum of Th 
cells  at  different  stages  of differentiation  (Fig.  6  C).  Im- 
mune  regulation in  vivo will most likely restrict the  fre- 
quency of completely differentiated and polarized Thl  and 
Th2 clones within the population. However, these cells may 
play an important role in determining the extent of pathol- 
ogy, by their production  of high levels of cytokines. Our 
data suggest that it may be possible to override the control- 
ling influence  of such  clones producing extreme  levels of 
cytokines. For example, the  administration of antigen to- 
gether with the polarizing conditions will enhance a change 
in Th  phenotype by the recruitment of naive and/or un- 
committed cells, which will undoubtedly be present even 
Figure  6.  Model  for reversal of Th  phenotypes. The 
model for heterogeneity ofTh phenotypes and their rever- 
sal is based on: (A and B) data obtained from flow cyto- 
metric analysis  of intraceUular cytokine synthesis in polar- 
ized Thl and Th2 populations obtained from TCIt.-~/13 
transgenic CD4 + T  cells stimulated in vitro with  APCs 
plus OVA in the presence of IL-12 plus anti-IL-4 mAbs 
(Thl) or IL-4 (Th2) for (A) 1 wk or (B) 3 wk, as in Figs. 
1-3.  (C) The prediction of the heterogeneity of Th phe- 
notypes and their reversal during an immune response in 
vivo. 
during chronic  disease.  These  cells, by differentiation and 
clonal outgrowth, will suppress the dominant Th phenotype 
as modeled from our flow cytometric analysis of IFN-~/- and 
IL-4-producing cells in  the  in  vitro  reversal  of polarized 
Th  cell populations.  The  ability of IL-4 to  downregulate 
IFN-~/-producing cells may indicate that it may be  more 
possible to  dampen  or revert inflammatory or Thl-medi- 
ated  pathologies,  than  atopic  or  chronic  Th2-dominated 
diseases, since IL-4--producing cells were more resistant to 
change.  In  these  situations it may be  necessary to  reduce 
the ongoing immune response as well as to restimulate the 
populations in the presence oflL-12 plus anti-IL-4 in order 
to outnumber and suppress dominant clones of a Th2 phe- 
notype. 
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